QT Imaging (NASDAQ:QTI) Upgraded at Zacks Research

Zacks Research upgraded shares of QT Imaging (NASDAQ:QTI) from a strong sell rating to a hold rating in a research note released on Monday morning,Zacks.com reports.

Several other equities research analysts have also commented on the stock. Weiss Ratings began coverage on shares of QT Imaging in a research report on Thursday, January 29th. They set a “sell (e+)” rating for the company. Lake Street Capital began coverage on shares of QT Imaging in a research report on Friday, January 30th. They set a “buy” rating for the company. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold”.

QT Imaging Price Performance

NASDAQ QTI opened at $6.96 on Monday. QT Imaging has a 52 week low of $0.65 and a 52 week high of $8.50. The firm has a market capitalization of $83.80 million, a P/E ratio of -3.18 and a beta of -0.09. The company has a quick ratio of 2.17, a current ratio of 2.81 and a debt-to-equity ratio of 0.71. The company has a 50-day moving average price of $6.29 and a 200-day moving average price of $5.73.

QT Imaging (NASDAQ:QTI) last released its quarterly earnings results on Wednesday, February 18th. The company reported ($0.10) EPS for the quarter. The firm had revenue of $8.27 million for the quarter. Equities research analysts anticipate that QT Imaging will post -0.18 earnings per share for the current year.

QT Imaging Company Profile

QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.

QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.